Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Toda

The company had attracted much interest due to its heavy use of artificial intelligence, but its latest fundamentals disappointed many.

Related Keywords

Chris Gibson , Recursion Pharmaceuticals , Motley Fool Stock Advisor , Stock Advisor , Recursion ,